OTHERClinicalTrials.govClinical trialRecruiting
Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS)
Official record
- Identifier
NCT04797299- Recruiting locations
country
Canada- Interventions studied
- Not provided in the official record
- Lead sponsor
- Ontario Clinical Oncology Group (OCOG)
- Target enrolment
- 526 participants
- Study type
- OBSERVATIONAL
- Phase
- Not provided in the official record
- Status
- Recruiting
- First posted
- Mar 15, 2021
- Last updated on the registry
- Aug 14, 2026
- Age
- 46 Years
- Sex
- FEMALE
- Study contact
- The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.
- Eligibility criteria
Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.
Inclusion Criteria: 1. Female patient \> 45 years of age with DCIS without microinvasion. 2. Tumour size ≤ 2.5cm. 3. Treated by BCS with clear resection margins ≥ 2 mm or no residual disease on re-excision.\* \* Patients with anterior margins and posterior margins ≥1 mm are eligible. Or if the dissection was confirmed to be taken to skin and down to fascia with no DCIS present at inked margins. 4. Oncotype DX DCIS score with a predicted 10-year risk of LR ≤10%. Exclusion Criteria: 1. Multifocal DCIS. 2. History of any invasive breast cancer or non-invasive breast cancer in the ipsilateral breast. 3. Synchronous or previous invasive or non-invasive breast cancer. 4. Prior history of invasive cancer within the last 5 years, excluding non-melanoma skin cancers. 5. ECOG performance status ≥3. 6. Life expectancy \<10 years. 7. Geographic inaccessibility for follow-up.
- Indexed under
- Breast Cancer